Thomas Clozel

Founder

Now Founder, Owkin

Latest on AI4S.fyiFunding · Jun 7, 2022 · founderOwkin · Series B · part of $80M in aggregate with an upfront fee; equity share not broken out

Account linked from owkin.com · Avatar from their X account, taken 2026-09-28

Affiliations

Current

Founder · Owkinsince 2016cathaycapital.com ↗

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

About

Thomas Clozel is co-founder and CEO of Owkin, which he started in 2016 with Gilles Wainrib to apply AI to patient data for drug discovery and development. He is a medical doctor trained in Paris and New York, a former assistant professor of clinical onco-hematology at Hôpital Henri Mondor in Paris, and a former member of Ari Melnick's lab at Weill Cornell Medical College.

Read on 2026-09-29; for current roles see Affiliations above. Read at: owkin.com ↗ · pulse2.com ↗

Founded

OwkinDrug discovery · 2016 · 5 rounds on record · disclosed $216M · Series B part of $80M in aggregate with an upfront fee; equity share not broken out
Background: Hôpital Henri Mondor, Paris (clinical onco-haematology); Ari Melnick lab, Weill Cornell (as the company's own announcements put it)
Co-founders: Gilles Wainrib
Backed byBristol Myers Squibb Sanofi F-Prime Capital Eight Roads Ventures Otium Capital

Nothing else on the record names them yet.

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →